Killing tumor-associated bacteria with a liposomal antibiotic generates neoantigens that induce anti-tumor immune responses.

[1]  J. Wargo,et al.  Targeting the gut and tumor microbiota in cancer , 2022, Nature Medicine.

[2]  Y. Taur,et al.  Gut microbiome correlates of response and toxicity following anti-CD19 CAR T cell therapy , 2022, Nature Medicine.

[3]  Mengwei Xiao,et al.  Roseburia intestinalis: A Beneficial Gut Organism From the Discoveries in Genus and Species , 2021, Frontiers in Cellular and Infection Microbiology.

[4]  R. Geiger,et al.  Metabolic modulation of tumours with engineered bacteria for immunotherapy , 2021, Nature.

[5]  A. Nerland,et al.  Label-free quantitative proteomic analysis of the oral bacteria Fusobacterium nucleatum and Porphyromonas gingivalis to identify protein features relevant in biofilm formation. , 2021, Anaerobe.

[6]  Mingxia Li,et al.  Heat shock protein 70 attenuates hypoxia-induced apoptosis of pulmonary microvascular endothelial cells isolated from neonatal rats , 2021, Molecular medicine reports.

[7]  M. Dąbrowska,et al.  Stability of Metronidazole and Its Complexes with Silver(I) Salts under Various Stress Conditions , 2021, Molecules.

[8]  Mei U Wong,et al.  Vaxign2: the second generation of the first Web-based vaccine design program using reverse vaccinology and machine learning , 2021, Nucleic Acids Res..

[9]  J. Hasty,et al.  The microbiome and human cancer , 2021, Science.

[10]  E. Ruppin,et al.  Identification of bacteria-derived HLA-bound peptides in melanoma , 2021, Nature.

[11]  Dominik Żyro,et al.  Clinical Application and Efficacy of Silver Drug in Ophthalmology: A Literature Review and New Formulation of EYE Drops with Drug Silver (I) Complex of Metronidazole with Improved Dosage Form , 2021, Biomedicines.

[12]  Rebecca L. Holden,et al.  Personal neoantigen vaccines induce persistent memory T cell responses and epitope spreading in patients with melanoma , 2021, Nature Medicine.

[13]  A. Waisman,et al.  A noninflammatory mRNA vaccine for treatment of experimental autoimmune encephalomyelitis , 2021, Science.

[14]  Z. Szallasi,et al.  Cross-reactivity between tumor MHC class I–restricted antigens and an enterococcal bacteriophage , 2020, Science.

[15]  Louise J Newnham,et al.  Advances in Anti-Cancer Immunotherapy: Car-T Cell, Checkpoint Inhibitors, Dendritic Cell Vaccines, and Oncolytic Viruses, and Emerging Cellular and Molecular Targets , 2020, Cancers.

[16]  Noam Shental,et al.  The human tumor microbiome is composed of tumor type–specific intracellular bacteria , 2020, Science.

[17]  Effect of CYP3A4 genetic polymorphisms on pharmacokinetics of tinidazole , 2020, Journal of Chinese Pharmaceutical Sciences.

[18]  Rob Knight,et al.  Microbiome analyses of blood and tissues suggest cancer diagnostic approach , 2020, Nature.

[19]  Yingli Wang,et al.  Remote loading paclitaxel–doxorubicin prodrug into liposomes for cancer combination therapy , 2020, Acta pharmaceutica Sinica. B.

[20]  Ze Lu,et al.  Fusobacterium nucleatum promotes epithelial‐mesenchymal transiton through regulation of the lncRNA MIR4435‐2HG/miR‐296‐5p/Akt2/SNAI1 signaling pathway , 2020, The FEBS journal.

[21]  Jun Sun,et al.  Influence of the Gut Microbiome, Diet, and Environment on Risk of Colorectal Cancer. , 2020, Gastroenterology.

[22]  Ze Lu,et al.  Fusobacterium nucleatum Caused DNA Damage and Promoted Cell Proliferation by the Ku70/p53 Pathway in Oral Cancer Cells , 2019, DNA and cell biology.

[23]  Kenji Mizuguchi,et al.  Impact of quality trimming on the efficiency of reads joining and diversity analysis of Illumina paired-end reads in the context of QIIME1 and QIIME2 microbiome analysis frameworks , 2019, BMC Bioinformatics.

[24]  U. Eriksson,et al.  Microbiota-derived peptide mimics drive lethal inflammatory cardiomyopathy , 2019, Science.

[25]  C. Brock,et al.  Association of Prior Antibiotic Treatment With Survival and Response to Immune Checkpoint Inhibitor Therapy in Patients With Cancer. , 2019, JAMA oncology.

[26]  Christine B. Peterson,et al.  Tumor Microbiome Diversity and Composition Influence Pancreatic Cancer Outcomes , 2019, Cell.

[27]  Y. Lee,et al.  The Role of Gut Microbiota in Intestinal Inflammation with Respect to Diet and Extrinsic Stressors , 2019, Microorganisms.

[28]  Si-Xue Cheng,et al.  Phage-guided modulation of the gut microbiota of mouse models of colorectal cancer augments their responses to chemotherapy , 2019, Nature Biomedical Engineering.

[29]  Ligeng Xu,et al.  Relaxin gene delivery mitigates liver metastasis and synergizes with check point therapy , 2019, Nature Communications.

[30]  L. Radko,et al.  Silver(I) Complexes of the Pharmaceutical Agents Metronidazole and 4-Hydroxymethylpyridine: Comparison of Cytotoxic Profile for Potential Clinical Application , 2019, Molecules.

[31]  Paul D. Boudreau,et al.  The human gut bacterial genotoxin colibactin alkylates DNA , 2019, Science.

[32]  W. Garrett,et al.  Fusobacterium nucleatum — symbiont, opportunist and oncobacterium , 2018, Nature Reviews Microbiology.

[33]  Leaf Huang,et al.  Trapping of Lipopolysaccharide to Promote Immunotherapy against Colorectal Cancer and Attenuate Liver Metastasis , 2018, Advanced materials.

[34]  H. Yao,et al.  Fusobacterium and Colorectal Cancer , 2018, Front. Oncol..

[35]  Kunyu Qiu,et al.  Inorganic nanoparticles and the microbiome , 2018, Nano Research.

[36]  Leaf Huang,et al.  Synergistic and low adverse effect cancer immunotherapy by immunogenic chemotherapy and locally expressed PD-L1 trap , 2018, Nature Communications.

[37]  Jungbae Kim,et al.  Selective Killing of Pathogenic Bacteria by Antimicrobial Silver Nanoparticle-Cell Wall Binding Domain Conjugates. , 2018, ACS applied materials & interfaces.

[38]  N. Hunter,et al.  Metronidazole: an update on metabolism, structure-cytotoxicity and resistance mechanisms. , 2018, The Journal of antimicrobial chemotherapy.

[39]  Donna Neuberg,et al.  Analysis of Fusobacterium persistence and antibiotic response in colorectal cancer , 2017, Science.

[40]  A. Nerland,et al.  Quantitative proteomic analysis of extracellular matrix extracted from mono- and dual-species biofilms of Fusobacterium nucleatum and Porphyromonas gingivalis. , 2017, Anaerobe.

[41]  J. Li,et al.  Pharmacokinetics of the Individual Major Components of Polymyxin B and Colistin in Rats. , 2017, Journal of natural products.

[42]  Leaf Huang,et al.  Local and transient gene expression primes the liver to resist cancer metastasis , 2016, Science Translational Medicine.

[43]  Sergey Tarima,et al.  Handling Time-dependent Variables: Antibiotics and Antibiotic Resistance. , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[44]  Paul J. McMurdie,et al.  DADA2: High resolution sample inference from Illumina amplicon data , 2016, Nature Methods.

[45]  Jonathan L. Linehan,et al.  Focused Specificity of Intestinal Th17 Cells towards Commensal Bacterial Antigens , 2014, Nature.

[46]  J. Goedert,et al.  Human gut microbiome and risk for colorectal cancer. , 2013, Journal of the National Cancer Institute.

[47]  M. R. Rubinstein,et al.  Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating E-cadherin/β-catenin signaling via its FadA adhesin. , 2013, Cell host & microbe.

[48]  K. Katoh,et al.  MAFFT Multiple Sequence Alignment Software Version 7: Improvements in Performance and Usability , 2013, Molecular biology and evolution.

[49]  Pelin Yilmaz,et al.  The SILVA ribosomal RNA gene database project: improved data processing and web-based tools , 2012, Nucleic Acids Res..

[50]  S. Prabhu,et al.  Silver nanoparticles: mechanism of antimicrobial action, synthesis, medical applications, and toxicity effects , 2012, International Nano Letters.

[51]  B. Birren,et al.  Genomic analysis identifies association of Fusobacterium with colorectal carcinoma. , 2012, Genome research.

[52]  Richard A. Moore,et al.  Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma. , 2012, Genome research.

[53]  L. Eckmann,et al.  Pyruvate:ferredoxin oxidoreductase and thioredoxin reductase are involved in 5-nitroimidazole activation while flavin metabolism is linked to 5-nitroimidazole resistance in Giardia lamblia. , 2011, The Journal of antimicrobial chemotherapy.

[54]  C. Huttenhower,et al.  Metagenomic biomarker discovery and explanation , 2011, Genome Biology.

[55]  M. Ehlers,et al.  Rapid blue light induction of protein interactions in living cells , 2010, Nature Methods.

[56]  J. Gordon,et al.  Our unindicted coconspirators: human metabolism from a microbial perspective. , 2010, Cell metabolism.

[57]  Yongqun He,et al.  Vaxign: The First Web-Based Vaccine Design Program for Reverse Vaccinology and Applications for Vaccine Development , 2010, Journal of biomedicine & biotechnology.

[58]  William A. Walters,et al.  Global patterns of 16S rRNA diversity at a depth of millions of sequences per sample , 2010, Proceedings of the National Academy of Sciences.

[59]  William A. Walters,et al.  QIIME allows analysis of high-throughput community sequencing data , 2010, Nature Methods.

[60]  Paramvir S. Dehal,et al.  FastTree 2 – Approximately Maximum-Likelihood Trees for Large Alignments , 2010, PloS one.

[61]  L. Cantley,et al.  Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation , 2009, Science.

[62]  H. Clevers,et al.  Single Lgr5 stem cells build crypt–villus structures in vitro without a mesenchymal niche , 2009, Nature.

[63]  T. Thurnheer,et al.  Gingival crevice microbiota from Chinese patients with gingivitis or necrotizing ulcerative gingivitis. , 2004, European journal of oral sciences.

[64]  C. Tournay,et al.  Efficient detection and immunomagnetic sorting of specific T cells using multimers of MHC class I and peptide with reduced CD8 binding , 2000, Nature Medicine.

[65]  Y. Matsumura,et al.  Clinicopathologic and immunohistochemical study of early colorectal cancer with liver metastases , 1999, Journal of Gastroenterology.